MedPath
FDA Product

TEMOZOLOMIDE

Product approved by U.S. Food and Drug Administration (US)

Basic Information

TEMOZOLOMIDE

59923-713

Regulatory Information

59923-713

ANDA204639

C73584

February 2, 2024

USA

These highlights do not include all the information needed to use TEMOZOLOMIDE CAPSULES USP safely and effectively. See full prescribing information for TEMOZOLOMIDE CAPSULES USP. TEMOZOLOMIDE capsules USP, for oral use Initial U.S. Approval: 1999

HUMAN PRESCRIPTION DRUG LABEL

8

Company Information

833189835

Active Ingredients

PROPYLENE GLYCOL

Code: 6DC9Q167V3

Class Code: IACT

TARTARIC ACID

Code: W4888I119H

Class Code: IACT

SILICON DIOXIDE

Code: ETJ7Z6XBU4

Class Code: IACT

WATER

Code: 059QF0KO0R

Class Code: IACT

STEARIC ACID

Code: 4ELV7Z65AP

Class Code: IACT

GELATIN

Code: 2G86QN327L

Class Code: IACT

ANHYDROUS LACTOSE

Code: 3SY5LH9PMK

Class Code: IACT

POTASSIUM HYDROXIDE

Code: WZH3C48M4T

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

FERROSOFERRIC OXIDE

Code: XM0M87F357

Class Code: IACT

TEMOZOLOMIDE

Quantity: 250 mg in 1 1

Code: YF1K15M17Y

Class Code: ACTIB

AMMONIA

Code: 5138Q19F1X

Class Code: IACT

SODIUM STARCH GLYCOLATE TYPE A POTATO

Code: 5856J3G2A2

Class Code: IACT

SHELLAC

Code: 46N107B71O

Class Code: IACT

Active Moieties

TEMOZOLOMIDE

Code: YF1K15M17Y

© Copyright 2025. All Rights Reserved by MedPath